Insulet Corp (NASDAQ:PODD)

217.55
BATS BZX Real-Time Price
As of 1:23pm ET
 -8.78 / -3.88%
Today’s Change
181.00
Today|||52-Week Range
324.81
-18.24%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$15.8B

Company Description

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Contact Information

Insulet Corp.
100 Nagog Park
Acton Massachusetts 01720
P:(978) 600-7000
Investor Relations:
(978) 600-7717

Employees

Shareholders

Mutual fund holders78.22%
Other institutional25.93%
Individual stakeholders22.52%

Top Executives

James R. HollingsheadPresident, Chief Executive Officer & Director
Charles AlpucheChief Operations Officer & Executive VP
Wayde Dwight McMillanChief Financial Officer, Treasurer & Executive VP
Trang LySenior Vice President & Medical Director
Michael P. SpearsSenior VP-Quality, Regulatory Affairs & Compliance